Loading…
Based on limited metadata, this FDA Warning Letter issued to Sprout Pharmaceuticals, Inc. on August 31, 2020, involves violations related to drug products. Without access to the full letter text or detailed subject information, the specific nature of the violations cannot be determined from the metadata provided. The warning falls under FDA's drug regulatory authority, though the particular issuing office and violation categories are not specified in the available information.